1887

Abstract

Envelope glycoprotein D (gD) of pseudorabies virus (PRV) is essential for penetration but is not required for cell-to-cell spread. When animals are inoculated with a phenotypically complemented PRV gD mutant, the virus is able to spread locally by means of direct cell-to-cell transmission, but progeny virions released by infected cells are non-infectious because they lack gD. Therefore, the virus cannot be transmitted from inoculated animals to other animals. This property makes a PRV gD mutant an attractive candidate as a safe vaccine vector. To examine whether a self-restricted, non-transmissible PRV mutant can be used as a biologically safe vaccine vector, a gD/gE-negative PRV recombinant virus which expresses envelope glycoprotein E2 of classical swine fever virus was constructed. Vaccination of pigs showed that the recombinant virus was able to protect pigs against both Aujeszky’s disease and classical swine fever.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-78-12-3311
1997-12-01
2023-02-06
Loading full text...

Full text loading...

/deliver/fulltext/jgv/78/12/9400982.html?itemId=/content/journal/jgv/10.1099/0022-1317-78-12-3311&mimeType=html&fmt=ahah

References

  1. Baxby D., Paoletti E. 1992; Potential use of non-replicating vectors as recombinant vaccines. Vaccine 10:8–9
    [Google Scholar]
  2. De Leeuw P. W., van Oirschot J. T. 1985; Vaccines against Aujeszky’s disease: evaluation of their efficacy under standardized laboratory conditions. Veterinary Quarterly 7:191–197
    [Google Scholar]
  3. Dong J., Roth M. G., Hunter E. 1992; A chimeric avian retrovirus containing the influenza virus hemagglutinin gene has an expanded host range. Journal of Virology 66:7374–7382
    [Google Scholar]
  4. Farrell H., McLean C. S., Harley C., Efstathiou S., Inglis S. C., Minson A. C. 1994; Vaccine potential of a herpes simplex virus type 1 mutant with an essential glycoprotein deleted. Journal of Virology 68:927–932
    [Google Scholar]
  5. Heffner S., Kovacs F., Klupp B., Mettenleiter T. C. 1993; Glycoprotein gp50-negative pseudorabies virus : a novel approach toward a nonspreading live herpesvirus vaccine. Journal of Virology 67:1529–1537
    [Google Scholar]
  6. Hilleman M. R. 1994; Recombinant vector vaccines in vaccinology. Developments in Biological Standardization 82:3–20
    [Google Scholar]
  7. Hulst M. M., Westra D. F., Wensvoort G., Moormann R. J. M. 1993; Glycoprotein E1 of hog cholera virus expressed in insect cells protects swine from hog cholera. Journal of Virology 67:5435–5442
    [Google Scholar]
  8. Kimman T. G. 1992; Risks connected with the use of conventional and genetically engineered vaccines. Veterinary Quarterly 15:110–118
    [Google Scholar]
  9. Mettenleiter T. C., Klupp B. G., Weiland F., Visser N. 1994; Characterization of a quadruple glycoprotein-deleted pseudorabies virus mutant for use as a biologically safe live virus vaccine. Journal of General Virology 75:1723–1733
    [Google Scholar]
  10. Moormann R. J. M., de Rover T., Briaire J., Peeters B. P. H., Gielkens A. L. J., van Oirschot J. T. 1990a; Inactivation of the thymidine kinase gene of a gI deletion mutant of pseudorabies virus generates a safe but still highly immunogenic vaccine strain. Journal of General Virology 71:1591–1595
    [Google Scholar]
  11. Moormann R. J. M., Warmerdam P. A. M., van der Meer B., Schaaper W. M. M., Wensvoort G., Hulst M. M. 1990b; Molecular cloning and nucleotide sequence of hog cholera virus strain Brescia and mapping of the genomic region encoding envelope protein E1. Virology 177:184–198
    [Google Scholar]
  12. Mulder W., Pol J., Kimman T., Kok G., Priem J., Peeters B. 1996; Glycoprotein D-negative pseudorabies virus can spread transneuronally via direct neuron-to-neuron transmission in its natural host, the pig, but not after additional inactivation of gE or gI. Journal of Virology 70:2191–2200
    [Google Scholar]
  13. Nguyen L. H., Knipe D. M., Finberg R. W. 1992; Replication-defective mutants of herpes simplex virus (HSV) induce cellular immunity and protect against lethal HSV infection. Journal of Virology 66:7067–7072
    [Google Scholar]
  14. Peeters B., de Wind N., Hooisma M., Wagenaar F., Gielkens A., Moormann R. 1992; Pseudorabies virus envelope glycoproteins gp50 and gII are essential for virus penetration, but only gII is involved in membrane fusion. Journal of Virology 66:894–905
    [Google Scholar]
  15. Peeters B., Pol J., Gielkens A., Moormann R. 1993; Envelope glycoprotein gp50 of pseudorabies virus is essential for virus entry but is not required for viral spread in mice. Journal of Virology 67:170–177
    [Google Scholar]
  16. Peeters B., Bouma A., de Bruin T., Moormann R., Gielkens A., Kimman T. 1994; Non-transmissible pseudorabies virus gp50- mutants: a new generation of safe live vaccines. Vaccine 12:375–380
    [Google Scholar]
  17. Peeters B., Kimman T., Pol J., Moormann R., Gielkens A. 1995; gD-negative herpesvirus: a new generation of safe live vaccines and carrier vaccines. In Vaccines 95 pp. 305–310 Chanock R. M., Brown F., Ginsberg H. S., Norrby E. Edited by Cold Spring Harbor, NY: Cold Spring Harbor Laboratory;
    [Google Scholar]
  18. Rauh I., Mettenleiter T. C. 1992; Pseudorabies virus glycoproteins gII and gp50 are essential for virus penetration. Journal of Virology 65:5348–5356
    [Google Scholar]
  19. Schmidt J., Klupp B. G., Mettenleiter T. C. 1997; Adaptability of herpesviruses : glycoprotein D-independent infectivity of pseudorabies virus. Journal of Virology 71:17–24
    [Google Scholar]
  20. Terpstra C., Bloemraad M., Gielkens A. L. J. 1984; The neutralizing peroxidase-linked assay for detection of antibody against swine fever virus. Veterinary Microbiology 9:113–120
    [Google Scholar]
  21. van Oirschot J. T., Houwers D. J., Rziha H.-J., van Zaane D. 1988; Development of an ELISA for detection of antibodies to glycoprotein I of Aujeszky’s disease virus: a method for the serological differentiation between infected and vaccinated pigs. Journal of Virological Methods 22:191–206
    [Google Scholar]
  22. van Zijl M., Wensvoort G., de Kluyver E., Hulst M., van der Gulden H., Gielkens A., Berns A., Moormann R. 1991; Live attenuated pseudorabies virus expressing envelope glycoprotein E1 of hog cholera virus protects swine against both pseudorabies and hog cholera. Journal of Virology 65:2761–2765
    [Google Scholar]
  23. Wensvoort G., Bloemraad M., Terpstra C. 1988; An enzyme immunoassay employing monoclonal antibodies and detecting specifically antibodies to classical swine fever virus. Veterinary Microbiology 17:129–140
    [Google Scholar]
  24. Wensvoort G., Boonstra J., Bodzinga B. G. 1990; Immunoaffinity purification and characterization of the envelope protein E1 of hog cholera virus. Journal of General Virology 71:531–540
    [Google Scholar]
  25. Yilma T. 1994; Genetically engineered vaccines for animal viral diseases. Journal of the American Veterinary Medical Association 204:1606–1615
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-78-12-3311
Loading
/content/journal/jgv/10.1099/0022-1317-78-12-3311
Loading

Data & Media loading...

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error